These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Primate and feline lentivirus vector RNA packaging and propagation by heterologous lentivirus virions. Browning MT; Schmidt RD; Lew KA; Rizvi TA J Virol; 2001 Jun; 75(11):5129-40. PubMed ID: 11333894 [TBL] [Abstract][Full Text] [Related]
8. Development of minimal lentivirus vectors derived from simian immunodeficiency virus (SIVmac251) and their use for gene transfer into human dendritic cells. Mangeot PE; Nègre D; Dubois B; Winter AJ; Leissner P; Mehtali M; Kaiserlian D; Cosset FL; Darlix JL J Virol; 2000 Sep; 74(18):8307-15. PubMed ID: 10954529 [TBL] [Abstract][Full Text] [Related]
12. Development of an Rev-independent, minimal simian immunodeficiency virus-derived vector system. Pandya S; Boris-Lawrie K; Leung NJ; Akkina R; Planelles V Hum Gene Ther; 2001 May; 12(7):847-57. PubMed ID: 11339901 [TBL] [Abstract][Full Text] [Related]
13. Lentivirus vectors using human and simian immunodeficiency virus elements. White SM; Renda M; Nam NY; Klimatcheva E; Zhu Y; Fisk J; Halterman M; Rimel BJ; Federoff H; Pandya S; Rosenblatt JD; Planelles V J Virol; 1999 Apr; 73(4):2832-40. PubMed ID: 10074131 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of choroidal neovascularization via brief subretinal exposure to a newly developed lentiviral vector pseudotyped with Sendai viral envelope proteins. Murakami Y; Ikeda Y; Yonemitsu Y; Miyazaki M; Inoue M; Hasegawa M; Sueishi K; Ishibashi T Hum Gene Ther; 2010 Feb; 21(2):199-209. PubMed ID: 19778186 [TBL] [Abstract][Full Text] [Related]
15. Genetic manipulation of primate embryonic and hematopoietic stem cells with simian lentivirus vectors. Hanazono Y; Asano T; Ueda Y; Ozawa K Trends Cardiovasc Med; 2003 Apr; 13(3):106-10. PubMed ID: 12691674 [TBL] [Abstract][Full Text] [Related]
16. MLV-derived retroviral vectors selective for CD4-expressing cells and resistant to neutralization by sera from HIV-infected patients. Stitz J; Steidl S; Merget-Millitzer H; König R; Müller P; Nocken F; Engelstädter M; Bobkova M; Schmitt I; Kurth R; Buchholz CJ; Cichutek K Virology; 2000 Feb; 267(2):229-36. PubMed ID: 10662618 [TBL] [Abstract][Full Text] [Related]
17. Viral determinants of integration site preferences of simian immunodeficiency virus-based vectors. Monse H; Laufs S; Kuate S; Zeller WJ; Fruehauf S; Uberla K J Virol; 2006 Aug; 80(16):8145-50. PubMed ID: 16873270 [TBL] [Abstract][Full Text] [Related]
18. A novel lentivirus vector derived from apathogenic simian immunodeficiency virus. Stitz J; Mühlebach MD; Blömer U; Scherr M; Selbert M; Wehner P; Steidl S; Schmitt I; König R; Schweizer M; Cichutek K Virology; 2001 Dec; 291(2):191-7. PubMed ID: 11878888 [TBL] [Abstract][Full Text] [Related]
19. Rev-independent expression of synthetic gag-pol genes of human immunodeficiency virus type 1 and simian immunodeficiency virus: implications for the safety of lentiviral vectors. Wagner R; Graf M; Bieler K; Wolf H; Grunwald T; Foley P; Uberla K Hum Gene Ther; 2000 Nov; 11(17):2403-13. PubMed ID: 11096444 [TBL] [Abstract][Full Text] [Related]
20. Potent inhibition of simian immunodeficiency virus (SIV) replication by an SIV-based lentiviral vector expressing antisense Env. Braun SE; Lu XV; Wong FE; Connole M; Qiu G; Chen Z; Slepushkina T; Slepushkin V; Humeau LM; Dropulic B; Johnson RP Hum Gene Ther; 2007 Jul; 18(7):653-64. PubMed ID: 17600461 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]